Search results
- 0.4668Add to watchlist+0.0059 (+1.28%)At close:4:00 PM EDTMon. Jul 8, 20240.4700 +0.01 (+1.34%)After hrs:4:01 PM EDTMon. Jul 8, 2024Nasdaq Real Time Price (USD) · Market closed
- Open0.4600High0.4701Low0.4521
- Mkt Cap7.47MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.460952 Wk. Low0.360052 Wk. High3.1400
Related stocks
Find the latest Cadrenal Therapeutics, Inc. (CVKD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Apr 12, 2024 · Get the latest stock price, news, and data for CVKD, a biotechnology company developing drugs for neurological disorders. See the bid, ask, volume, market cap, and other key metrics for CVKD on Nasdaq.
Jun 24, 2024 · CVKD is the ticker symbol for Cadrenal Therapeutics Inc., a biotechnology company developing drugs for inflammatory and fibrotic diseases. The stock price, performance, analyst ratings, news and other key data are shown on this page.
Get the latest Cadrenal Therapeutics Inc (CVKD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
4 days ago · Should You Buy or Sell Cadrenal Therapeutics Stock? Get The Latest CVKD Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- 4
- cadrenal@lythampartners.com
5 days ago · CVKD is a biopharmaceutical company developing tecarfarin, a novel oral and reversible anticoagulant for rare cardiovascular conditions. See the latest stock price, news, financials, statistics, forecast, profile, chart and more on Stock Analysis.
People also ask
Should you buy CVKD stock?
Where is CVKD headquartered?
Is cadrenal Therapeutics (CVKD) a good growth stock in 2024?
Jul 2, 2024 · A high-level overview of Cadrenal Therapeutics, Inc. (CVKD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
